M
108.14
-0.22 (-0.20%)
Penutupan Terdahulu | 108.36 |
Buka | 109.53 |
Jumlah Dagangan | 289,022 |
Purata Dagangan (3B) | 454,171 |
Modal Pasaran | 6,302,334,464 |
Harga / Pendapatan (P/E TTM) | 52.75 |
Harga / Pendapatan (P/E Ke hadapan) | 28.57 |
Harga / Jualan (P/S) | 4.80 |
Harga / Buku (P/B) | 4.76 |
Julat 52 Minggu | |
Tarikh Pendapatan | 25 Feb 2025 |
Margin Keuntungan | 9.05% |
Margin Operasi (TTM) | 10.99% |
EPS Cair (TTM) | 2.05 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 7.80% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | 10.10% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 61.90% |
Nisbah Semasa (MRQ) | 5.36 |
Aliran Tunai Operasi (OCF TTM) | 214.31 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 162.97 M |
Pulangan Atas Aset (ROA TTM) | 4.55% |
Pulangan Atas Ekuiti (ROE TTM) | 9.40% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
Stok | Merit Medical Systems, Inc. | Menaik | Menaik |
AISkor Stockmoo
1.9
Konsensus Penganalisis | 4.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -0.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | 4.0 |
Purata | 1.88 |
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue. |
|
Sektor | Healthcare |
Industri | Medical Instruments & Supplies |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 3.34% |
% Dimiliki oleh Institusi | 106.48% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 128.00 (Canaccord Genuity, 18.37%) | Beli |
Median | 118.00 (9.12%) | |
Rendah | 110.00 (Raymond James, 1.72%) | Beli |
Purata | 118.50 (9.58%) | |
Jumlah | 6 Beli | |
Harga Purata @ Panggilan | 106.03 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Barrington Research | 29 Jan 2025 | 115.00 (6.34%) | Beli | 108.48 |
23 Dec 2024 | 114.00 (5.42%) | Beli | 97.61 | |
Canaccord Genuity | 29 Jan 2025 | 128.00 (18.37%) | Beli | 108.48 |
09 Dec 2024 | 127.00 (17.44%) | Beli | 102.09 | |
Needham | 29 Jan 2025 | 122.00 (12.82%) | Beli | 108.48 |
14 Jan 2025 | 109.00 (0.80%) | Beli | 99.89 | |
Piper Sandler | 29 Jan 2025 | 116.00 (7.27%) | Beli | 108.48 |
21 Jan 2025 | 114.00 (5.42%) | Beli | 104.40 | |
Raymond James | 31 Dec 2024 | 110.00 (1.72%) | Beli | 96.72 |
Wells Fargo | 11 Dec 2024 | 120.00 (10.97%) | Beli | 105.52 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
13 Jan 2025 | Pengumuman | Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025 |
20 Dec 2024 | Pengumuman | Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis |
16 Dec 2024 | Pengumuman | Merit Medical Announces Resignation of President, Joseph Wright |
25 Nov 2024 | Pengumuman | Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |